0000-0002-4086-1716 Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas Save
- Concentration–QTc Analysis of Valemetostat in Patients With Hematologic Malignancies Save
- Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug–Drug Interaction Study in Patients With Non‐Hodgkin Lymphoma Save
- Datopotamab deruxtecan (Dato-DXd) in locally advanced/metastatic urothelial cancer: Updated results from the phase 1 TROPIONPanTumor01 study. Save
- Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study Save
- Efficacy and safety of a nebulizer formulation of laninamivir octanoate against seasonal influenza in pediatric patients: an uncontrolled, open-label phase 3 study Save
- Efficacy and safety of laninamivir octanoate nebulizer inhalation versus placebo: a randomized, single-blind, placebo-controlled, parallel-group, multicenter phase 3 study Save
- Datopotamab deruxtecan in locally advanced/metastatic urothelial cancer: Preliminary results from the phase 1 TROPION-PanTumor01 study. Save
- The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas Save
- Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia Save